1. Covalent inhibition of P. falciparum ferredoxin-NADP + reductase: Exploring alternative strategies for the development of new antimalarial drugs.
- Author
-
de Rosa M, Nonnis S, and Aliverti A
- Subjects
- Antineoplastic Agents, Alkylating chemistry, Antineoplastic Agents, Alkylating metabolism, Antineoplastic Agents, Alkylating pharmacology, Biocatalysis drug effects, Carmustine chemistry, Carmustine metabolism, Carmustine pharmacology, Catalytic Domain, Cysteine chemistry, Cysteine metabolism, Diamide chemistry, Diamide metabolism, Diamide pharmacology, Enzyme Inhibitors chemistry, Enzyme Inhibitors metabolism, Ferredoxin-NADP Reductase chemistry, Ferredoxin-NADP Reductase metabolism, Kinetics, Malaria, Falciparum parasitology, Molecular Structure, NADP metabolism, Organomercury Compounds chemistry, Organomercury Compounds metabolism, Organomercury Compounds pharmacology, Plasmodium falciparum enzymology, Plasmodium falciparum physiology, Protein Binding, Protein Domains, Protozoan Proteins chemistry, Protozoan Proteins metabolism, Substrate Specificity, Enzyme Inhibitors pharmacology, Ferredoxin-NADP Reductase antagonists & inhibitors, Malaria, Falciparum prevention & control, Plasmodium falciparum drug effects, Protozoan Proteins antagonists & inhibitors
- Abstract
The protozoan Plasmodium falciparum is the main aetiological agent of tropical malaria. Characteristic of the phylum is the presence of a plastid-like organelle which hosts several homologs of plant proteins, including a ferredoxin (PfFd) and its NADPH-dependent reductase (PfFNR). The PfFNR/PfFd redox system is essential for the parasite, while mammals share no homologous proteins, making the enzyme an attractive target for novel and much needed antimalarial drugs. Based on previous findings, three chemically reactive residues important for PfFNR activity were identified: namely, the active-site Cys99, responsible for hydride transfer; Cys284, whose oxidation leads to an inactive dimeric form of the protein; and His286, which is involved in NADPH binding. These amino acid residues were probed by several residue-specific reagents and the two cysteines were shown to be promising targets for covalent inhibition. The quantitative and qualitative description of the reactivity of few compounds, including a repurposed drug, set the bases for the development of more potent and specific antimalarial leads., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF